These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10771815)

  • 21. Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
    Balgir RS
    Homo; 2006; 57(2):163-76. PubMed ID: 16603161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle cell syndromes: misdiagnosis can affect treatment.
    Golden WE; Moore G
    J Ark Med Soc; 2004 Nov; 101(5):144-5. PubMed ID: 15554178
    [No Abstract]   [Full Text] [Related]  

  • 24. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival.
    Fleming AF; Storey J; Molineaux L; Iroko EA; Attai ED
    Ann Trop Med Parasitol; 1979 Apr; 73(2):161-72. PubMed ID: 315211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proficiency testing of hemoglobinopathy techniques in Ontario laboratories.
    Lafferty J; Ali MA; Carstairs K; Crawford L
    Am J Clin Pathol; 1997 May; 107(5):567-75. PubMed ID: 9128270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.
    Al-Rimawi HS; Abdul-Qader M; Jallad MF; Amarin ZO
    J Trop Pediatr; 2006 Dec; 52(6):416-20. PubMed ID: 16951418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal haemoglobins, thalassaemia and G-6-PD enzyme deficiency in Rajasthan (western-India).
    Choubisa SL
    Haematologia (Budap); 1991; 24(3):153-65. PubMed ID: 1841846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of sickle cell disease in a rural hospital of central India.
    Kamble M; Chatruvedi P
    Indian Pediatr; 2000 Apr; 37(4):391-6. PubMed ID: 10781232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Student screening for inherited blood disorders in Bahrain.
    Al-Arrayed S; Hafadh N; Amin S; Al-Mukhareq H; Sanad H
    East Mediterr Health J; 2003 May; 9(3):344-52. PubMed ID: 15751927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sickling syndromes in children.
    Honig GR
    Adv Pediatr; 1976; 23():271-313. PubMed ID: 795281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
    Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
    Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sickle Cell Disease in Central India: A Potentially Severe Syndrome.
    Jain D; Warthe V; Dayama P; Sarate D; Colah R; Mehta P; Serjeant G
    Indian J Pediatr; 2016 Oct; 83(10):1071-6. PubMed ID: 27053181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemoglobin SD disease].
    Laws HJ; Dickerhoff R; Mayer J; Köster B
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):708-10. PubMed ID: 8413345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from eastern India.
    Patel DK; Mashon RS; Patel S; Das BS; Purohit P; Bishwal SC
    Hemoglobin; 2012; 36(5):409-20. PubMed ID: 22881992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and laboratory features of sickle cell disease in The Netherlands.
    Aluoch JR; De Geus A; Goudsmit R
    Trop Geogr Med; 1988 Jan; 40(1):7-12. PubMed ID: 3381319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orofacial pain in patients with sickle cell disease.
    O'Rourke C; Mitropoulos C
    Br Dent J; 1990 Sep; 169(5):130-2. PubMed ID: 2206667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haematological change in sickle cell-haemoglobin C disease and in sickle cell-beta thalassaemia: a cohort study from birth.
    Stevens MC; Maude GH; Beckford M; Grandison Y; Mason K; Serjeant BE; Taylor B; Topley JM; Serjeant GR
    Br J Haematol; 1985 Jun; 60(2):279-92. PubMed ID: 4005180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.